Fibroblast heterogeneity in the pancreatic tumor microenvironment

E Helms, MK Onate, MH Sherman - Cancer discovery, 2020 - AACR
The poor prognosis for patients with pancreatic ductal adenocarcinoma (PDAC) impels an
improved understanding of disease biology to facilitate the development of better therapies …
被引用次数：247 相关文章

Fibroblast heterogeneity in the pancreatic tumor microenvironment

E Helms, MK Onate, MH Sherman - Cancer discovery, 2020 - ohsu.elsevierpure.com
The poor prognosis for patients with pancreatic ductal adenocarcinoma (PDAC) impels an
improved understanding of disease biology to facilitate the development of better therapies …

Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment

E Helms, MK Onate, MH Sherman - Cancer discovery, 2020 - pubmed.ncbi.nlm.nih.gov
The poor prognosis for patients with pancreatic ductal adenocarcinoma (PDAC) impels an
improved understanding of disease biology to facilitate the development of better therapies …

Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment

E Helms, MK Onate, MH Sherman - Cancer Discovery, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title/>< jats: p> The poor prognosis for
patients with pancreatic ductal adenocarcinoma (PDAC) impels an improved understanding …
[HTML] nih.gov

[HTML][HTML] Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment

E Helms, MK Onate, MH Sherman - Cancer discovery, 2020 - ncbi.nlm.nih.gov
The poor prognosis for pancreatic ductal adenocarcinoma (PDAC) patients impels an
improved understanding of disease biology, to facilitate the development of better therapies …

Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment.

E Helms, MK Onate, MH Sherman - Cancer Discovery, 2020 - europepmc.org
The poor prognosis for pancreatic ductal adenocarcinoma (PDAC) patients impels an
improved understanding of disease biology, to facilitate the development of better therapies …